SUZANNE DECKER: Open Payments
NPI 1326373457 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 29 payments from 12 companies in 2025. Trend: 2023 $427 · 2024 $553 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $347 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| PFIZER INC. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Amgen Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| bioMerieux Inc | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, UBRELVY, TRELEGY ELLIPTA, NURTEC ODT, EVENITY, AIRSUPRA, JARDIANCE.
Industry payments across ID — which companies pay providers there.
